Cost-utility analysis of the fixed-dose combination of dolutegravir/abacavir/lamivudine as initial treatment of HIV+ patients in Spain

1. Guillén, S.M.
2. García, J.E.L.
3. Berenguer, J.B.
4. Sesmero, J.M.M.
5. Gomis, S.C.
6. Graefehain, R.
7. Sánchez-Cambronero, D.L.
8. García, F.J.P.